| Peripheral blood mononuclear cells (PBMCs) |
|  | | Produced using a human-like protein expression platform |
|
 |
| Efficient transfection of siRNA into mammalian cells |
|  | | sterilize lightly contaminated laboratory tools |
|
 |
| Express toxic proteins or insoluble proteins in a soluble form |
|  | |
Genlantis is focused on developing innovative reagents for transfection, gene expression, Gene Silencing, RNA interference, primary cell culture, and sample preparation in proteomics research. We are dedicated to serving the needs of life science researchers worldwide by embracing innovation.